Resvent Revenue and Competitors

作为全球高速成长的呼吸健康数字医疗解决方案提供商，在呼吸慢病诊断与治疗、重症机械通气、AI及数字医疗，和智能云信息系统等领域,深入洞察临床应用需求，依托自身强大研发实力迸发创造潜能,持续创新推出高品质医疗解决方案。与您一起，应对医疗及健康新挑战，持续输出高性能价格比的 数字化医疗及慢病管理解决方案。融昕坚持自主创新,目前已拥有国内外注册专利、商标百余项。产品获得中国NMPA认证、欧盟CE认证、美国FDA EUA。融昕医疗解决方案已服务于中国、亚洲、欧洲、美洲、 澳洲、非洲等全球60多个国家和地区,遍布全球的营销与服务网络，为客户提供高效专业的定制化服务，赢得了客户的信赖。 融昕始终关注呼吸健康、关注客户需求，并快速响应、不断融合创新、优化医疗成本,让更多人可以分享优质的医疗关怀。融昕更深知自己的社会责任，新冠肺炎疫情期间，融昕产品驰援全球多个国家，积极助力抗疫。 As a global fast-growing  solution provider for respiratory health，Resvent provides in-depth insight into clinical application needs in the areas of  chronic respiratory disease diagnosis & treatment, critical mechanical ventilation, Al and digital healthcare, and intelligent cloud information system, and continues to innovate and deliver high-quality medical solutions based on its strong research and development capabilities. So, together with You,  Resvent will meet the new medical and healthcare challenges and continuously output  high-performance and cost-effective solutions for digital medical and chronic disease management .Resvent insists on independent innovation and currently has more than 100 domestic and foreign registered patents and trademarks. Products have obtained China NMPA, CE, FDA EUA certification. Its integrated medical solutions and customized service have won customers from more than 60 countries and regions around the world.Resvent focuses on respiratory health and customer needs closely, insists on quick response, continuous integration and innovation, optimizes medical costs to let more people share quality medical care. Resvent is more aware of its social responsibilities. During the Coronavirus (COVID-19) pandemic, its products rushed to assist many countries around the world to actively help fight the epidemic